By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Bristol Myers Squibb

Bristol Myers Squibb’s Opdivo regimen granted FDA approval in NSCLC PMLiVE12:35FDA Cancer Treatment Cancer

FDA approval give BMS an edge in NSCLC treatment pharmaphorum11:31FDA Cancer Treatment Cancer

Bristol Myers Squibb stock rises after schizophrenia drug gets FDA approval Investopedia16:34FDA Pharma

A “Game-changing” new drug for schizophrenia? Boston University17:15FDA Pharma

BMS achieves FDA approval for schizophrenia drug Cobenfy Biopharma Reporter15:28Personality Disorder FDA Pharma

Schizophrenia treatment revolution: FDA approves Bristol Myers Squibb' Cobenfy as new class of treatment in more than 3 … Benzinga12:58Personality Disorder FDA Pharma

Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis PMLiVE12:45Sotyktu Psoriasis

Prime Medicine inks cell therapy pact with Bristol Myers Squibb worth over $3.5B, Streamlines pipeline Benzinga13:40Pharma

Clinic researchers build first large-scale atlas of how immune cells react to mutations during… ecancer14:42Cancer Treatment Cancer Global Health

FDA approves new Bristol Myers Squibb schizophrenia drug Yahoo! US16:06FDA Pharma

BMS and 2seventy bio to discontinue enrolment in multiple myeloma trial Clinical Trials Arena11:29Blood Cancer Cancer Treatment Cancer

Bristol Myers Squibb presents data for Multiple Sclerosis drug Zeposia, shows long-term efficacy Benzinga14:59Zeposia Multiple Sclerosis Health

Long-term survival rates improve with dual immunotherapy in metastatic melanoma Pharmacy Times18:14Cancer Treatment Pharma Cancer

Latest News

Yesterday

For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's… FiercePharma08:12 7-Oct-24

In the last 7 days

Bristol Myers Squibb: A High-Yield Bargain With Growth On The Horizon Seeking Alpha17:12 6-Oct-24

Segal Trials Plays Key Role in FDA Approval of COBENFY™, A New Era in Schizophrenia Treatment Business Wire (Press Release)15:24 4-Oct-24

Bristol Myers Squibb’s Opdivo regimen granted FDA approval in NSCLC PMLiVE12:35 4-Oct-24

FDA approval give BMS an edge in NSCLC treatment pharmaphorum11:31 4-Oct-24

BMS receives FDA approval for Opdivo to treat NSCLC Pharmaceutical Technology11:29 4-Oct-24

U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo®… Business Wire (Press Release)22:40 3-Oct-24

Notable Thursday Option Activity: IMKTA, HIMS, BMY Nasdaq20:53 3-Oct-24

A “Game-Changing” New Drug for Schizophrenia? Boston University17:15 3-Oct-24

2 Passive-Income Stocks to Load Up On in October The Motley Fool11:52 3-Oct-24

Long BMY: Bristol Myers Squibb Breaks Out After Positive Trial Data and FDA Approval, Targeting … Invezz14:51 2-Oct-24

Clinic researchers build first large-scale atlas of how immune cells react to mutations during… ecancer14:42 2-Oct-24

Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis PMLiVE12:45 2-Oct-24

Progentos Therapeutics Appoints Andrew Miller, Ph.D. to Chairman of its Board of Directors Business Wire (Press Release)12:32 2-Oct-24

Cleveland Clinic researchers build first large-scale atlas of how immune cells react to mutations during cancer… Newswise (Press Release)21:28 1-Oct-24

Got $100? Consider Buying These 2 Penny Stocks in October (PRME, RLX) 24/7 Wall St.20:27 1-Oct-24

BMS achieves FDA approval for schizophrenia drug Cobenfy Biopharma Reporter15:28 1-Oct-24

BMS and Prime ink potential $3.5bn deal to develop T cell therapies Pharmaceutical Technology14:52 1-Oct-24

In the last month

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community Initiatives in the… PR Newswire (Press Release)16:57 30-Sept-24

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline Benzinga13:40 30-Sept-24

Prime Medicine Unveils Strategically Focused Pipeline GlobeNewswire (Press Release)12:11 30-Sept-24

3 Surprisingly Underrated Stocks to Buy Right Now The Motley Fool12:41 28-Sept-24

Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval Seeking Alpha10:50 28-Sept-24

FDA Approves First New Schizophrenia Drug In 30 Years: Cobenfy Offers Hope With Fewer Side Effects | Details Outlook India06:15 28-Sept-24

Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade) Seeking Alpha19:48 27-Sept-24

Bristol-Myers Squibb: Unlocking Value With KarXT FDA Approval And Oncology Pipeline Progress Seeking Alpha19:48 27-Sept-24

FDA Approves Schizophrenia Treatment that Targets Cholinergic Receptors PharmTech.com19:44 27-Sept-24

BMS wins approval for schizophrenia drug acquired from Karuna Pharmaceutical Technology19:41 27-Sept-24

Nasdaq 100 and S&P 500 Weekly Gains: Inflation Eases, Fed Rate Cuts in Focus FX Empire19:26 27-Sept-24

Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval Investopedia16:34 27-Sept-24

Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib)… Business Wire (Press Release)16:10 27-Sept-24

FDA approves new Bristol Myers Squibb schizophrenia drug Yahoo! US16:06 27-Sept-24

The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment Quartz15:42 27-Sept-24

U.S. Regulator Approves Bristol Myers Squibb’s (NYSE:BMY) Schizophrenia Drug TipRanks15:28 27-Sept-24

Bristol Myers Squibb shares move higher on FDA approval of schizophrenia drug Proactive Investors (Canada)14:47 27-Sept-24

FDA Approves New Drug for Schizophrenia TIME14:29 27-Sept-24

FDA approves Cobenfy: A breakthrough Schizophrenia treatment after decades The Times of India13:26 27-Sept-24

Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 … Benzinga12:58 27-Sept-24

BMS ends decades-long drought in novel schizophrenia drugs pharmaphorum09:24 27-Sept-24

PureTech receives $29m royalty from Karuna schizophrenia treatment London South East07:45 27-Sept-24

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment… Business Wire (Press Release)07:02 27-Sept-24

FDA approves a novel drug for schizophrenia, a potential ‘game changer’ The Seattle Times02:50 27-Sept-24

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and… Business Wire (Press Release)02:12 27-Sept-24

Bristol Myers Squibb's Karuna buyout pays off with FDA approval for novel schizophrenia med… FiercePharma00:42 27-Sept-24

FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in… NECN, New England00:13 27-Sept-24

BMS and 2seventy bio to discontinue enrolment in multiple myeloma trial Clinical Trials Arena11:29 26-Sept-24

FDA Casts Doubt On Use Of Merck, Bristol Myers' Pd-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients Benzinga21:01 25-Sept-24

Bristol Myers Squibb Employees bike cross-country to Battle Cancer ABC7 / KGO-TV16:36 25-Sept-24

2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter… Business Wire (Press Release)11:07 25-Sept-24

Bristol Myers Squibb axes 79 more in NJ as $1.5B cost-reduction program rolls on FiercePharma19:22 20-Sept-24

Bristol Myers Squibb Co. v. Becerra; Janssen Pharmaceuticals v. Becerra Public Citizen19:15 20-Sept-24

Carrick Group to acquire Bristol-Myers Squibb’s Irish captive insurers Reinsurance News06:32 19-Sept-24

Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy Benzinga14:59 18-Sept-24

New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in… Business Wire (Press Release)12:00 18-Sept-24

Long-Term Survival Rates Improve with Dual Immunotherapy in Metastatic Melanoma Pharmacy Times18:14 17-Sept-24

ESMO 2024: BMS cuts ties as Immatics regains full rights to bispecific Clinical Trials Arena15:46 17-Sept-24

What Analysts Are Saying About Bristol-Myers Squibb Stock Benzinga22:55 16-Sept-24

Pharma Companies’ Challenge to Inflation Reduction Act Heats Up IPWatchdog.com18:08 16-Sept-24

3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade The Motley Fool10:29 16-Sept-24

Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed… Business Wire (Press Release)13:59 15-Sept-24

ESMO 2024: BMS scores with ES-SCLC drug in patients with brain metastases Clinical Trials Arena19:20 13-Sept-24

Frontline BMS-986012 Plus Nivolumab/Chemotherapy Shows Promise in ES-SCLC OncLive18:22 13-Sept-24

Carrick Group expands with acquisition of two captives Insurance Business Magazine US15:25 13-Sept-24

One Mind Hosts 30th Annual Music Festival for Brain Health, Celebrating Three Decades of… Business Wire (Press Release)14:35 12-Sept-24

Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024 Business Wire (Press Release)12:05 12-Sept-24

Prodrugs and patents: Enhancing therapy adherence and reducing side effects Pharmaceutical Technology08:53 11-Sept-24

Bristol Myers Squibb Announces Dividend Business Wire (Press Release)22:48 10-Sept-24

Is Bristol-Myers Squibb Stock Underperforming the S&P 500? Barchart18:17 10-Sept-24

Seventh Circuit Decision Marks Win for Employers in FLSA Nationwide Collective Actions JD Supra19:37 9-Sept-24

Avadomide hydrochloride by Bristol-Myers Squibb for Glioblastoma Multiforme (GBM): Likelihood… Pharmaceutical Technology19:25 9-Sept-24

Avadomide hydrochloride by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval Pharmaceutical Technology19:25 9-Sept-24

KOS-1803 by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval Pharmaceutical Technology19:25 9-Sept-24

Bristol Myers Squibb staffers start pedaling against cancer as 3,000-mile fundraising push gets … FiercePharma16:26 9-Sept-24

September 2025 Options Now Available For Bristol Myers Squibb (BMY) Nasdaq16:25 9-Sept-24

Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in… Business Wire (Press Release)12:04 9-Sept-24

CC-115 by Bristol-Myers Squibb for Glioblastoma Multiforme (GBM): Likelihood of Approval Pharmaceutical Technology10:07 9-Sept-24

BMS-813160 by Bristol-Myers Squibb for Hepatocellular Carcinoma: Likelihood of Approval Pharmaceutical Technology10:07 9-Sept-24

DF-1001 by Bristol-Myers Squibb for Colorectal Cancer: Likelihood of Approval Pharmaceutical Technology07:54 9-Sept-24

Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade) Seeking Alpha15:37 7-Sept-24

view more headlines

7 Oct 08:12

Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.